Telo Genomics Corp., 2026-04-24
An SEC Form D private-offering notice from Vancouver, BC, Canada, a $19,100 filer-stated offering target in Biotech. Filed 2026-04-24. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Biotechnology company developing a telomere based diagnostic and prognostic platform for cancer and neurological disease, based in Vancouver, British Columbia.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Converge Bio Inc., 2026-04-28, $25M, Claymont, DE
- CASI Pharmaceuticals, Inc., 2026-04-28, $5M, Beijing
- NK-One Therapeutics, Inc., 2026-04-27, $310K, Wayne, PA
- Neuro-Kinesis Corp, 2026-04-24, $2M, Inglewood, CA
- Life Biosciences LLC, 2026-04-24, $31M, Boston, MA
- BIOVENTRIX, INC., 2026-04-24, $10M, Mansfield, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.